Health Care Distributors

160 HEALTH

Health 160 Accelerates Commercialization of Medical AI Scenes in Collaboration with Lightelligence

Health 160 Upgrades AI Hospital Products with DeepSeek-V4

Health 160's '160AI Hospital' Model Achieves 102 Public Medical Institutions Partnership

Health 160 Announced a Narrowed Loss of 72.986 Million Yuan for Full Year 2025

160 HEALTH released FY2024 Q3 earnings on March 27 (BJT), actual revenue HKD 192.24 M, actual EPS HKD -0.0493

160 HEALTH released FY2025 Annual Earnings on March 27 (BJT), with actual revenue of HKD 712.47 M and EPS of HKD -0.2623

160 HEALTH released FY2024 Q4 earnings on March 27, 2026 (BJT), actual revenue HKD 184.51 M, actual EPS HKD -0.0473

160 HEALTH released FY2024 9 Months earnings on March 27 (BJT), actual revenue HKD 487.34 M, actual EPS HKD -0.3524

160 HEALTH released FY2025 9 Months earnings on March 27 (BJT), actual revenue HKD 513.2M, actual EPS HKD -0.1638

160 HEALTH released FY2025 Q3 earnings on March 27, 2026 (BJT), with actual revenue of HKD 197.43 M and EPS of HKD -0.0939

160 HEALTH released FY2025 Q4 earnings on March 27 (BJT), actual revenue HKD 200.84 M, actual EPS HKD -0.0955

Health 160 Announces Revenue Growth and Reduced Loss for FY2025

160 HEALTH to Release FY2025 Earnings Report on March 27, 2026 (BJT)

160 Health International Expects Profit Improvement in FY 2025

160 Health International Sees Significant Growth in Signing Operational Cooperation Agreements with Public Hospitals

Health 160 International Integrates AI into Products and Services, Significantly Boosting Operational Efficiency

Health 160 launches 160 Cloud Hospital, offering digital empowerment for medical institutions and users

160 HEALTH released FY2024 Q2 earnings on September 29 (BJT), actual revenue HKD 193.04 M, actual EPS HKD -0.1612

160 HEALTH released FY2025 Q2 earnings on September 29 (BJT), actual revenue HKD 208.17 M, actual EPS HKD -0.0134

160 HEALTH released FY2025 Semi-Annual earnings on September 29 (BJT), actual revenue HKD 314.72 M, actual EPS HKD -0.0704

CH DEMETER FIN

FAMEGLOW

LUEN THAI

NEW GONOW RV

REF HOLDINGS

PARADISE ENT

WEBX HOLDING

HAICHANG HLDG

BEST FOOD HLDG

INTELLIMARK W27

02656

160 HEALTH fell 10.63%; Sinopharm Group fell 0.11%, with a transaction volume of HKD 89.32 million; Shanghai Pharmaceuticals rose 0.41%, with a transaction volume of HKD 51.38 million; Baiyunshan rose 0.36%, with a transaction volume of HKD 31.46 million; GUANZE MEDICAL fell 9.65%, with a market value of HKD 6.042 billion

HK Stock Alerts

SINOPHARM

SH PHARMA

BAIYUNSHAN PH

GUANZE MEDICAL

Hong Kong stock movement: 160 HEALTH falls over 10%, market volatility intensifies, capital flow attracts attention

02706

06660

00580

02865

02617

02477

00259

00596

02940

160 HEALTH(02656) rose 44.26%, with a trading turnover 2.4 Billion HKD, and a year-to-date fell 57.9%. HAIZHI TECH GP(02706) rose 25.96%, with a trading turnover 363.0 Million HKD, and a year-to-date rose 129.5%. AIM VACCINE(06660) rose 21.83%, with a trading turnover 10.6 Million HKD, and a year-to-date fell 4.4%.

Top Gainers&Losers

HAIZHI TECH GP

AIM VACCINE

SUN.KING TECH

DRINDA

TRANSTHERA-B

WELLCELL HOLD

YEEBO (INT'L H)

INSPUR DIGI ENT

Top 10 HK Stock Gainers (5.8)

01808

08529

00465

03296

Hong Kong stock market overview in the past hour Market sentiment seems to be gradually warming up amid recent fluctuations, especially with small-cap stocks and technology stocks performing actively. There is a noticeable inflow of funds into the health and technology sectors, driving overall gains, and short-term enthusiasm is continuously rising. Meanwhile, the divergence in strength among individual stocks is becoming increasingly apparent, with capital preferences seemingly shifting towards high-growth stocks, resulting in a faster overall pace and increased volatility. In the past hour, the standout stock with the most significant movement is 160 HEALTH, which surged by 45.64%, attracting a lot of short-term capital attention, and the market sentiment is high, seemingly laying a good foundation for its subsequent performance. The strong performance of this stock has also boosted the activity of related sectors, creating a positive linkage effect. Strong stocks: 1. ENTERPRISE DEV: up 20.83%, recent optimistic expectations for its prospects have driven a rapid increase in its stock price, with short-term capital actively participating. 2. WELLCELL HOLD (new): up 16.09%, this stock has attracted considerable capital inflow against the backdrop of rising market enthusiasm, showing strong upward momentum. 3. WELLCELL HOLD (old): up 16.00%, echoing the performance of the new stock, indicating sustained market attention. 4. UBOT HOLDING: up 13.64%, short-term capital inflow has steadily increased its stock price, with market sentiment improving. 5. HUAQIN: up 10.55%, against the backdrop of an overall recovery in technology stocks, this stock has also gained favor with investors, showing good upward momentum

ENTERPRISE DEV

UBOT HOLDING

FUTONG TECH

HUAQIN

Hong Kong Stock Movement Update: 160 HEALTH surges 45.64%, ENTERPRISE DEV rises 20.83% leading the market

159938

159929

512010

健康 160（2656.HK）现价 22.460，当日 +40.02%，盘中涨幅居港股前列，市值 79.1 亿。公司聚焦医疗健康与 AI 应用。数字医疗场景加速兑现，叠加 “流量中介” 到 “Token 工厂” 业务模式转型，多重利好刺激资金追捧。板块内科技赋能和市场主题驱动，推动健康 160 强势爆发。

Movers Alert

GF CSI All Share Health Care ETF

China Universal 800 Health Care ETF

E Fund CSI 300 Health Care ETF

Ping An Healthcare (2656.HK) Soars 40% on AI Momentum

160 HEALTH surged 45.64%; China National Pharmaceutical Group fell 1.82%, with a transaction volume of HKD 80.07 million; Shanghai Pharmaceuticals fell 0.82%, with a transaction volume of HKD 31.03 million; GUANZE MEDICAL rose 9.08%, with a transaction volume of HKD 11.26 million; Baiyunshan fell 0.47%, with a market value of HKD 27.3 billion

Hong Kong Stock Movement: 160 HEALTH surged 45.64%, driven by the dual benefits of AI technology and the Hong Kong Stock Connect, igniting market confidence

160 HEALTH surged 20.82%; Sinopharm Group fell 1.60%, with a transaction volume of HKD 39.52 million; Shanghai Pharmaceuticals fell 1.15%, with a transaction volume of HKD 20.66 million; GUANZE MEDICAL rose 4.46%, with a transaction volume of HKD 4.35 million; Baiyunshan fell 0.18%, with a market value of HKD 27.3 billion

Hong Kong stock movement: 160 HEALTH surged 20.82%, AI technology helps turn losses into profits, market enthusiasm is high but risks must be heeded

160 HEALTH rose by 16.77%; Sinopharm Group fell by 1.66%, with a transaction volume of HKD 39.12 million; Shanghai Pharmaceuticals fell by 0.99%, with a transaction volume of HKD 19.77 million; GUANZE MEDICAL rose by 3.85%, with a transaction volume of HKD 4.15 million; Baiyunshan fell by 0.18%, with a market value of HKD 27.3 billion

Hong Kong stock movement: 160 HEALTH rose by 16.77%, AI technology leads a new era in medical services, significantly boosting market confidence!

160 HEALTH rose by 16.25%; China National Pharmaceutical Group rose by 1.02%, with a transaction volume of HKD 56.14 million; Shanghai Pharmaceuticals rose by 0.66%, with a transaction volume of HKD 9.52 million; Baiyunshan had a transaction volume of HKD 3.16 million; GUANZE MEDICAL rose by 1.83%, with a market value of HKD 5.814 billion

Hong Kong stock movement: 160 HEALTH rose 16.25%, AI technology leads market confidence, valuation speculation intensifies!

02661

02635

01333

01277

02685

03881

02575

09993

06651

QINGSONG HEALTH(02661) fell 31.33%, with a trading turnover 116.0 Million HKD, and a year-to-date fell 42.2%. 160 HEALTH(02656) fell 17.82%, with a trading turnover 223.0 Million HKD, and a year-to-date fell 71.9%. NUOBIKAN(02635) fell 16.81%, with a trading turnover 145.9 Million HKD, and a year-to-date fell 46.5%.

QINGSONG HEALTH

NUOBIKAN

BRETON

KINETIC DEV

QUANTGROUP

CIDI

XUANZHUBIO-B

RADIANCE HLDGS

51WORLD

Top 10 HK Stock Losers (5.6)

160 HEALTH fell by 15.05%; Sinopharm Group rose by 0.16%, with a transaction volume of HKD 47.64 million; Shanghai Pharmaceuticals fell by 0.66%, with a transaction volume of HKD 33.07 million; Baiyunshan rose by 0.84%, with a transaction volume of HKD 15.24 million; GUANZE MEDICAL fell by 1.77%, with a market value of HKD 5.786 billion

Hong Kong stock movement: 160 HEALTH fell by 15.05%, AI medical innovation and the inclusion of Hong Kong Stock Connect triggered significant market fluctuations

160 HEALTH(02656.HK)